UnitedHealth Group Stock Steady Amid Q2 Growth, Analysts See 16% Upside

UnitedHealth Group stock remained stable on August 23, 2026, as investors processed its solid second-quarter growth in health insurance and services. The company reported higher revenue and earnings compared to Q2 2025, driven by membership expansion and value-based care contracts.

The Q2 2026 performance built upon the prior year's results, with UnitedHealth Group completing its fiscal year with revenue and profit growth. The fresh figures are more relevant for investors now as they fall within a nine-month freshness window.

Analysts currently assign UnitedHealth Group a consensus rating of Moderate Buy, with an average price target of $455.92, indicating potential upside of 16 to 17 percent from the current trading level of $390.94.